-
Trident nerve out-of-road treatment of brain stem disease safe and effective
Time of Update: 2020-06-03
The extra-upper path of the trigeminal nerve and the entry path through the outer side of the foot of the cerebellum are suitable for the treatment of lesions that extend to the level below and above
-
Comparison of the efficacy of non-functional pituitary large adenomas in early and late GKRS treatment
Time of Update: 2020-06-03
I Jonathan Pomeraniec and others analyzed the prognosis of gamma knife treatment for a totally extophanome-butterfly large adenoma to assess the effect of the timing of treatment on efficacy, the resu
-
IDH1/2 mutations associated with grade II, II/III and III brain gliomas
Time of Update: 2020-06-03
IDH1 is located on chromosome 2q33 and encodes the IDH1 enzyme to catalyze the oxidation of isocric acid to alpha-ketone diacid, resulting in the production of pyridine adenine dinucleotide phosphate
-
Phase II Clinical Trial Results for iniparib's Treatment of Glioblastoma
Time of Update: 2020-06-03
Glioblastoma patients are more or less resistant to existing treatment options As a newly developed drug, Iniparib has a unique mechanism of action, combining radiotherapy and tamoxifen with 17.2 mg/k
-
Mass spectrometry detection 2-HG to quickly diagnose IDH mutations
Time of Update: 2020-06-03
Traditional PCR sequencing and immunohistomydization require more than 1 day to get the test results, which is not suitable for rapid diagnosis Therefore, on the basis of previous discoveries, the aut
-
Four molecular markers of glioma
Time of Update: 2020-06-03
The initial IDH mutation was closely related to the formation of low-level glioma, followed by 1p/19q co-miss, TERT mutation or P53 and ATRX mutation; - From the article chapter (Ruff: Ruff: Ruff: R
-
Effect of complementary treatment on the survival of patients with grade II glioma
Time of Update: 2020-06-02
Taeryool Koo, of the Radiation Oncology Department at Halm University's Sacred Heart Hospital in Anyang City, South Korea, and others assessed the complementary therapeutic effects of radiation and ch
-
The interval between non-small cell lung cancer and brain metastasis affects the prognosis of patients
Time of Update: 2020-06-02
Deborah R Smith of the Department of Radiation Oncology at Columbia University's Irvine Medical Center and others study the effects of brain metastasis in non-small cell lung cancer on prognosis, and
-
LGG in auxiliary sports area is prone to cognitive impairment
Time of Update: 2020-06-02
The Brodmann 6 is located in the front of the primary motor cortex and consists of anauxiliary motor area ,SMA , the former SMA and the former motor cortex , which have complex anatomy and functional
-
Accelerated progression after the recurrence of IDH mutant glioma
Time of Update: 2020-06-02
Background isocric acid dehydrogenase (IDH) mutant glioma is a unique subtype, the 2016 edition of WHO central nervous system tumor classification as a molecular diagnosis as an important part of gli
-
Molecular genetic background of chrysanthemum-forming glial neuronal tumors
Time of Update: 2020-06-02
Background chrysanthemum-form glial neuronal tumor (Rosette-forming glioneuronal tumor, RGNT) is a rare central nervous system tumor that is good at young patients RGNT is often born in the fourth ve
-
New perspective on low-level glioma removal
Time of Update: 2020-06-02
Background diffuse low-level glioma (DLGG) continues to migrate throughout the brain until evil changes, so early treatment has replaced traditional follow-up observations The study of cognitive neur
-
Study on GBM for non-viral delivery therapy of antiangiogenic factors
Time of Update: 2020-06-02
Anne Clavreul of neurosurgery at the University of Ange in France uses non-viral methods such as enhanced delivery devices (CED devices), implantable polymer devices, nanocarriers or cell vectors to enable angiogenesis inhibitors to perform anti-tumor angiogenesis in intracranial insinuate GBM animal models The findings were published in the April 2019 Issue of International Journal of Nanomedicine - From the article Ref: Clavreul A , et al.
-
The use of new chemotherapy drug paste stoics in the tumor cavity to treat GBM effectively
Time of Update: 2020-06-02
Stuart J Smith, of the Children's Brain Tumor Research Centre at the University of Nottingham School of Medicine in the UK, and others conducted an animal model study of gliomatos to assess the value
-
Characteristics of glioblastoma in adult cerebellum
Time of Update: 2020-06-02
The results were published online december 2017 in journal of Neuro-Oncology in 17 adult cerebellum GBM patients in retrospective studies, such as Thi?baud Picart of the Civilian Hospice Hospital in L
-
5-ALA fluorescence display level is related to GBM histological characteristics
Time of Update: 2020-06-02
Barbara Kiesel of the Medical University of Vienna, Austria, and others studied the correlation between GBM fluorescence visualization and tumor histological characteristics, and the results were published in the August 2018 issue of J Neurosurg - From the article Ref: Kiesel B , et al.
-
Immune response between tumor innewborn antigen vaccine and T cells in GBM
Time of Update: 2020-06-02
Derin B Keskin of Oncology at the Dana Cancer Institute in Boston, USA, conducted phase I/Ib studies on the treatment of glioblastoma (GBM) for the vaccination of newborn antigens in tumors, and the results were published in the January 2019 issue of nature - From the article Ref: Keskin DB , et al.
-
Adverse prognosis of multiple body and 1p/19q common deletion of less protogliolitoplasm
Time of Update: 2020-06-02
A recent study published in the journal Neuro-oncology, entitled Polysomy is with poor poor outcome in 1p19q co-deleted oligodroglial tumors, demonstrated a negative prognosis associated with the comm
-
Study on the mechanism of RESISTANCE of MET inhibitors by GBM
Time of Update: 2020-06-02
Nichola Cruickshanks, of the University of Virginia's Immunology and Cancer Biology, and others studied the drug resistance mechanisms of MET inhibitors in GBM and developed new ways to overcome them The findings were published in the January 2019 issue of Clinical Cancer Research - From the article Ref: Cruickshanks N , et al.
Clin Cancer Res.
2019 Jan 15;25 (2):663-673 doi: 10.1158/1078-0432.CCR-18-0926 Epub 2018 Sep 10.
-
Secondary radiation therapy for recurrent ventricular membrane tumors in children
Time of Update: 2020-06-02
The prognosis of WHO class II or class III children's ventricular tube membrane tumors is poor After the new ventricular tube membrane tumor was surgically removed and combined radiotherapy, 1/3 of th
